Global Iohexol Injection Market Research Report 2021

1 Iohexol Injection Market Overview

• 1.1 Product Overview and Scope of Iohexol Injection
• 1.2 Iohexol Injection Segment by Type
  • 1.2.1 Global Iohexol Injection Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 350mg I/ml
  • 1.2.3 240mg I/ml
  • 1.2.4 300mg I/ml
  • 1.2.5 Others
• 1.3 Iohexol Injection Segment by Application
  • 1.3.1 Global Iohexol Injection Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
• 1.4 Global Iohexol Injection Market Size Estimates and Forecasts
  • 1.4.1 Global Iohexol Injection Revenue 2016-2027
  • 1.4.2 Global Iohexol Injection Sales 2016-2027
  • 1.4.3 Iohexol Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Iohexol Injection Market Competition by Manufacturers

• 2.1 Global Iohexol Injection Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Iohexol Injection Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Iohexol Injection Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Iohexol Injection Manufacturing Sites, Area Served, Product Type
• 2.5 Iohexol Injection Market Competitive Situation and Trends
  • 2.5.1 Iohexol Injection Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Iohexol Injection Players Market Share by Revenue
  • 2.5.3 Global Iohexol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Iohexol Injection Retrospective Market Scenario by Region

• 3.1 Global Iohexol Injection Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Iohexol Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Iohexol Injection Market Facts & Figures by Country
  • 3.3.1 North America Iohexol Injection Sales by Country
  • 3.3.2 North America Iohexol Injection Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Iohexol Injection Market Facts & Figures by Country
  • 3.4.1 Europe Iohexol Injection Sales by Country
  • 3.4.2 Europe Iohexol Injection Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Iohexol Injection Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Iohexol Injection Sales by Region
  • 3.5.2 Asia Pacific Iohexol Injection Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Iohexol Injection Market Facts & Figures by Country
  • 3.6.1 Latin America Iohexol Injection Sales by Country
  • 3.6.2 Latin America Iohexol Injection Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Iohexol Injection Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Iohexol Injection Sales by Country
  • 3.7.2 Middle East and Africa Iohexol Injection Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Iohexol Injection Historic Market Analysis by Type

• 4.1 Global Iohexol Injection Sales Market Share by Type (2016-2021)
• 4.2 Global Iohexol Injection Revenue Market Share by Type (2016-2021)
• 4.3 Global Iohexol Injection Price by Type (2016-2021)

5 Global Iohexol Injection Historic Market Analysis by Application

• 5.1 Global Iohexol Injection Sales Market Share by Application (2016-2021)
• 5.2 Global Iohexol Injection Revenue Market Share by Application (2016-2021)
• 5.3 Global Iohexol Injection Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 GE Healthcare
  • 6.1.1 GE Healthcare Corporation Information
  • 6.1.2 GE Healthcare Description and Business Overview
  • 6.1.3 GE Healthcare Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 GE Healthcare Iohexol Injection Product Portfolio
  • 6.1.5 GE Healthcare Recent Developments/Updates
• 6.2 Imax
  • 6.2.1 Imax Corporation Information
  • 6.2.2 Imax Description and Business Overview
  • 6.2.3 Imax Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Imax Iohexol Injection Product Portfolio
  • 6.2.5 Imax Recent Developments/Updates
• 6.3 Grupo Juste
  • 6.3.1 Grupo Juste Corporation Information
  • 6.3.2 Grupo Juste Description and Business Overview
  • 6.3.3 Grupo Juste Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Grupo Juste Iohexol Injection Product Portfolio
  • 6.3.5 Grupo Juste Recent Developments/Updates
• 6.4 Daiichi Sankyo
  • 6.4.1 Daiichi Sankyo Corporation Information
  • 6.4.2 Daiichi Sankyo Description and Business Overview
  • 6.4.3 Daiichi Sankyo Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Daiichi Sankyo Iohexol Injection Product Portfolio
  • 6.4.5 Daiichi Sankyo Recent Developments/Updates
• 6.5 Takeda
  • 6.5.1 Takeda Corporation Information
  • 6.5.2 Takeda Description and Business Overview
  • 6.5.3 Takeda Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Takeda Iohexol Injection Product Portfolio
  • 6.5.5 Takeda Recent Developments/Updates
• 6.6 Fuji Pharma
  • 6.6.1 Fuji Pharma Corporation Information
  • 6.6.2 Fuji Pharma Description and Business Overview
  • 6.6.3 Fuji Pharma Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Fuji Pharma Iohexol Injection Product Portfolio
  • 6.6.5 Fuji Pharma Recent Developments/Updates
• 6.7 Towaseiyaku
  • 6.6.1 Towaseiyaku Corporation Information
  • 6.6.2 Towaseiyaku Description and Business Overview
  • 6.6.3 Towaseiyaku Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Towaseiyaku Iohexol Injection Product Portfolio
  • 6.7.5 Towaseiyaku Recent Developments/Updates
• 6.8 Hikari Pharmaceutical
  • 6.8.1 Hikari Pharmaceutical Corporation Information
  • 6.8.2 Hikari Pharmaceutical Description and Business Overview
  • 6.8.3 Hikari Pharmaceutical Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Hikari Pharmaceutical Iohexol Injection Product Portfolio
  • 6.8.5 Hikari Pharmaceutical Recent Developments/Updates
• 6.9 YRPG
  • 6.9.1 YRPG Corporation Information
  • 6.9.2 YRPG Description and Business Overview
  • 6.9.3 YRPG Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 YRPG Iohexol Injection Product Portfolio
  • 6.9.5 YRPG Recent Developments/Updates
• 6.10 BeiLu Pharma
  • 6.10.1 BeiLu Pharma Corporation Information
  • 6.10.2 BeiLu Pharma Description and Business Overview
  • 6.10.3 BeiLu Pharma Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 BeiLu Pharma Iohexol Injection Product Portfolio
  • 6.10.5 BeiLu Pharma Recent Developments/Updates

7 Iohexol Injection Manufacturing Cost Analysis

• 7.1 Iohexol Injection Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Iohexol Injection
• 7.4 Iohexol Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Iohexol Injection Distributors List
• 8.3 Iohexol Injection Customers

9 Iohexol Injection Market Dynamics

• 9.1 Iohexol Injection Industry Trends
• 9.2 Iohexol Injection Growth Drivers
• 9.3 Iohexol Injection Market Challenges
• 9.4 Iohexol Injection Market Restraints

10 Global Market Forecast

• 10.1 Iohexol Injection Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Iohexol Injection by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Iohexol Injection by Type (2022-2027)
• 10.2 Iohexol Injection Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Iohexol Injection by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Iohexol Injection by Application (2022-2027)
• 10.3 Iohexol Injection Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Iohexol Injection by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Iohexol Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List